REAL WORLD EVIDENCE OF LENVATINIB IN ADVANCED HEPATOCELLULAR CARCINOMA: A MULTICENTER COHORT STUDY

被引：0
|
作者：
Nakano, Masahito [1 ]
Kuromatsu, Ryoko [1 ]
Niizeki, Takashi [1 ]
Okamura, Shusuke [1 ]
Iwamoto, Hideki [1 ]
Shimose, Shigeo [1 ]
Shirono, Tomotake [1 ]
Noda, Yu [1 ]
Kamachi, Naoki [1 ]
Koga, Hironori [1 ]
Torimura, Takuji [1 ]
机构：
[1] Kurume Univ, Sch Med, Dept Med, Div Gastroenterol, Kurume, Fukuoka, Japan
来源：
HEPATOLOGY | 2019年 / 70卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
384
引用
收藏
页码：243A / 244A
页数：2
相关论文
共 50 条
  • [21] Efficacy and Safety of Lenvatinib for Patients With Advanced Hepatocellular Carcinoma: A Retrospective, Real-world Study Conducted in Japan
    Shimozato, Naotaka
    Namisaki, Tadashi
    Okano, Akihiro
    Ohana, Masaya
    Kinoshita, Daisuke
    Kawasaki, Toshihiko
    Aihara, Yosuke
    Nakatani, Toshiya
    Kinoshita, Hiroki
    Ann, Tatsuichi
    Saito, Ko
    Yoshida, Motoyuki
    Yoshiji, Hitoshi
    [J]. ANTICANCER RESEARCH, 2022, 42 (01) : 173 - 183
  • [22] Efficacy and safety of lenvatinib for patients with advanced hepatocellular carcinoma: A retrospective, real-world study conducted in China
    Wang, Dong-Xu
    Yang, Xu
    Lin, Jian-Zhen
    Bai, Yi
    Long, Jun-Yu
    Yang, Xiao-Bo
    Seery, Samuel
    Zhao, Hai-Tao
    [J]. WORLD JOURNAL OF GASTROENTEROLOGY, 2020, 26 (30) : 4465 - 4478
  • [23] The combination treatment strategy of lenvatinib for hepatocellular carcinoma: a real-world study
    Chen, Jinbin
    Xiong, Peiyao
    Nie, Man
    Pan, Yangxun
    Wang, Juncheng
    Hu, Dandan
    Zhou, Zhongguo
    Zhang, Yaojun
    Chen, Minshan
    Xu, Li
    [J]. JOURNAL OF CANCER RESEARCH AND CLINICAL ONCOLOGY, 2023, 149 (06) : 2491 - 2500
  • [24] The combination treatment strategy of lenvatinib for hepatocellular carcinoma: a real-world study
    Jinbin Chen
    Peiyao Xiong
    Man Nie
    Yangxun Pan
    Juncheng Wang
    Dandan Hu
    Zhongguo Zhou
    Yaojun Zhang
    Minshan Chen
    Li Xu
    [J]. Journal of Cancer Research and Clinical Oncology, 2023, 149 : 2491 - 2500
  • [25] ANALYSIS OF FACTORS RELATED TO THE TOLERABILITY OF LENVATINIB FOR PATIENTS WITH UNRESECTABLE HEPATOCELLULAR CARCINOMA IN REAL-WORLD CONDITIONS: A MULTICENTER STUDY
    Taniki, Nobuhito
    Nakamoto, Nobuhiro
    Chu, Po-Sung
    Shiba, Shunsuke
    Tahara, Toshiyuki
    Komatsu, Hirokazu
    Okamura, Yukishige
    Ojiro, Keisuke
    Kikuchi, Masahiro
    Aoki, Yu
    Yamaguchi, Akihiro
    Usui, Shingo
    Kanai, Takanori
    [J]. HEPATOLOGY, 2020, 72 : 689A - 689A
  • [26] Lenvatinib plus pembrolizumab versus lenvatinib in patients with unresectable hepatocellular carcinoma: A real world study.
    Lee, I-Cheng
    Wu, Chi-Jung
    Chen, San-Chi
    Chao, Yee
    Huang, Yi-Hsiang
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)
  • [27] The Real-World Data in Japanese Patients with Unresectable Hepatocellular Carcinoma Treated with Lenvatinib from a Nationwide Multicenter Study
    Tsuchiya, Kaoru
    Kurosaki, Masayuki
    Sakamoto, Azusa
    Marusawa, Hiroyuki
    Kojima, Yuji
    Hasebe, Chitomi
    Arai, Hirotaka
    Joko, Kouji
    Kondo, Masahiko
    Tsuji, Keiji
    Sohda, Tetsuro
    Kimura, Hiroyuki
    Ogawa, Chikara
    Uchida, Yasushi
    Wada, Shuichi
    Kobashi, Haruhiko
    Furuta, Koichiro
    Shigeno, Masaya
    Kusakabe, Atsunori
    Akahane, Takehiro
    Narita, Ryoichi
    Yoshida, Hideo
    Mitsuda, Akeri
    Ide, Yasushi
    Matsushita, Tomomichi
    Izumi, Namiki
    [J]. CANCERS, 2021, 13 (11)
  • [28] Lenvatinib in Advanced Hepatocellular Carcinoma
    Kudo, Masatoshi
    [J]. LIVER CANCER, 2017, 6 (04) : 253 - 263
  • [29] Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real-world setting
    Sho, Takuya
    Suda, Goki
    Ogawa, Koji
    Kimura, Megumi
    Shimazaki, Tomoe
    Maehara, Osamu
    Shigesawa, Taku
    Suzuki, Kazuharu
    Nakamura, Akihisa
    Ohara, Masatsugu
    Umemura, Machiko
    Kawagishi, Naoki
    Natsuizaka, Mitsuteru
    Nakai, Masato
    Morikawa, Kenichi
    Furuya, Ken
    Baba, Masaru
    Yamamoto, Yoshiya
    Kobayashi, Tomoe
    Meguro, Takashi
    Saga, Akiyoshi
    Miyagishima, Takuto
    Yokoo, Hideki
    Kamiyama, Toshiya
    Taketomi, Akinobu
    Sakamoto, Naoya
    [J]. JGH OPEN, 2020, 4 (01): : 54 - 60
  • [30] Early response and safety of lenvatinib for patients with advanced hepatocellular carcinoma in a real-world setting
    Sho, Takuya
    Suda, Goki
    Ogawa, Koji
    Nakai, Masato
    Morikawa, Kenichi
    Sakamoto, Naoya
    [J]. JOURNAL OF HEPATOLOGY, 2019, 70 (01) : E621 - E621
12345